Orrstown Financial Services’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $753K | Sell |
5,888
-362
| -6% | -$43.6K | 1.41% | 27 |
|
|
2021
Q4 | $762K | Sell |
6,250
-371
| -6% | -$48.6K | 1.16% | 39 |
|
|
2021
Q3 | $941K | Sell |
6,621
-75
| -1% | -$11K | 1.49% | 23 |
|
|
2021
Q2 | $1.06M | Sell |
6,696
-470
| -7% | -$76.1K | 1.53% | 21 |
|
|
2021
Q1 | $1.11M | Sell |
7,166
-221
| -3% | -$34.2K | 1.57% | 19 |
|
|
2020
Q4 | $1.1M | Sell |
7,387
-244
| -3% | -$34.5K | 1.63% | 16 |
|
|
2020
Q3 | $1.02M | Buy |
7,631
+291
| +4% | +$38K | 1.6% | 18 |
|
|
2020
Q2 | $851K | Sell |
7,340
-109
| -1% | -$12.6K | 1.4% | 30 |
|
|
2020
Q1 | $731K | Buy |
7,449
+27
| +0.4% | +$3.54K | 1.05% | 32 |
|
|
2019
Q4 | $1.07M | Sell |
7,422
-369
| -5% | -$50.9K | 1.53% | 26 |
|
|
2019
Q3 | $1.05M | Sell |
7,791
-95
| -1% | -$12.3K | 1.41% | 24 |
|
|
2019
Q2 | $901K | Buy |
7,886
+199
| +3% | +$23.3K | 1.23% | 35 |
|
|
2019
Q1 | $953K | Buy |
7,687
+497
| +7% | +$56.5K | 1.34% | 30 |
|
|
2018
Q4 | $724K | Sell |
7,190
-91
| -1% | -$10.2K | 1.09% | 46 |
|
|
2018
Q3 | $929K | Sell |
7,281
-757
| -9% | -$90K | 1.22% | 43 |
|
|
2018
Q2 | $870K | Sell |
8,038
-360
| -4% | -$39.2K | 1.08% | 47 |
|
|
2018
Q1 | $889K | Sell |
8,398
-296
| -3% | -$34.4K | 1.05% | 42 |
|
|
2017
Q4 | $1.02M | Sell |
8,694
-443
| -5% | -$50.1K | 1.17% | 39 |
|
|
2017
Q3 | $1.04M | Sell |
9,137
-1,487
| -14% | -$172K | 1.16% | 32 |
|
|
2017
Q2 | $1.32M | Sell |
10,624
-833
| -7% | -$98.8K | 1.45% | 18 |
|
|
2017
Q1 | $1.36M | Buy |
11,457
+411
| +4% | +$46.6K | 1.37% | 21 |
|
|
2016
Q4 | $1.09M | Buy |
11,046
+12
| +0.1% | +$1.29K | 1.12% | 38 |
|
|
2016
Q3 | $1.39M | Sell |
11,034
-993
| -8% | -$123K | 1.47% | 17 |
|
|
2016
Q2 | $1.41M | Sell |
12,027
-629
| -5% | -$71.2K | 1.51% | 16 |
|
|
2016
Q1 | $1.31M | Buy |
12,656
+170
| +1% | +$16.4K | 1.41% | 22 |
|
|
2015
Q4 | $1.24M | Buy |
12,486
+321
| +3% | +$31.4K | 1.35% | 27 |
|
|
2015
Q3 | $1.11M | Buy |
12,165
+210
| +2% | +$21.1K | 1.3% | 28 |
|
|
2015
Q2 | $1.27M | Buy |
11,955
+338
| +3% | +$37.4K | 1.38% | 26 |
|
|
2015
Q1 | $1.32M | Sell |
11,617
-1,008
| -8% | -$115K | 1.43% | 25 |
|
|
2014
Q4 | $1.39M | Sell |
12,625
-658
| -5% | -$69.4K | 1.47% | 29 |
|
|
2014
Q3 | $1.3M | Sell |
13,283
-1,311
| -9% | -$129K | 1.41% | 28 |
|
|
2014
Q2 | $1.47M | Buy |
14,594
+158
| +1% | +$15.4K | 1.56% | 27 |
|
|
2014
Q1 | $1.33M | Buy |
14,436
+1,102
| +8% | +$102K | 1.42% | 28 |
|
|
2013
Q4 | $1.21M | Buy |
13,334
+13,210
| +10,653% | +$1.14M | 1.26% | 30 |
|
|
2013
Q3 | $10K | Hold |
124
| – | – | 0.01% | 158 |
|
|
2013
Q2 | $9K | Buy |
+124
| New | +$9.27K | 0.01% | 155 |
|
Other funds holding ZBH
Orrstown Financial Services's ZBH Position: Q1 2022 in Review
Orrstown Financial Services reduced its Zimmer Biomet (ZBH) stake by 5.8% in Q1 2022, selling an estimated $43.6K and leaving 5,888 shares worth $753K. The position accounts for 1.41% of the portfolio, ranked #27.
Orrstown Financial Services first reported a position in ZBH in Q2 2013 and has held it in 36 quarters since. The position peaked at $1.47M in Q2 2014. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.
- Orrstown Financial Services held 5,888 shares of Zimmer Biomet worth $753K as of Q1 2022.
- Orrstown Financial Services sold 362 Zimmer Biomet shares in Q1 2022, an estimated $43.6K.
- Zimmer Biomet made up 1.41% of Orrstown Financial Services's portfolio in Q1 2022, its #27 holding.
- Orrstown Financial Services first reported a position in Zimmer Biomet in Q2 2013 and has held it in 36 quarters since.
- Orrstown Financial Services's Zimmer Biomet position peaked at $1.47M in Q2 2014.
- 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.
Based on Orrstown Financial Services's 13F filing for Q1 2022, filed 12 Apr 2022.